This activity was supported by the Agricultural Research Service of the U.S. Department of Agriculture (Grant # 59-0204-5-001); Health Canada (Contract No. 4500358459); the National Cancer Institute, ...
The U.S. Food and Drug Administration (FDA) announced Rare Disease Evidence Principles (RDEP) to allow for faster approval of treatments for ultra-rare genetic diseases. A product is eligible if it ...
On September 3, 2025, the US Food and Drug Administration (FDA) announced a new process to support the development of drugs intended to treat rare genetic diseases. The Rare Disease Evidence ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results